Bashir Tarig, Dorrello N Valerio, Amador Virginia, Guardavaccaro Daniele, Pagano Michele
Department of Pathology, MSB 599, New York University School of Medicine, and New York University Cancer Institute, 550 First Avenue, New York, New York 10016, USA.
Nature. 2004 Mar 11;428(6979):190-3. doi: 10.1038/nature02330.
Skp2 and its cofactor Cks1 are the substrate-targeting subunits of the SCF(Skp2-Cks1) (Skp1/Cul1/F-box protein) ubiquitin ligase complex that regulates entry into S phase by inducing the degradation of the cyclin-dependent kinase inhibitors p21 and p27 (ref. 1). Skp2 is an oncoprotein that often shows increased expression in human cancers; however, the mechanism that regulates its cellular abundance is not well understood. Here we show that both Skp2 and Cks1 proteins are unstable in G1 and that their degradation is mediated by the ubiquitin ligase APC/C(Cdh1) (anaphase-promoting complex/cyclosome and its activator Cdh1). Silencing of Cdh1 by RNA interference in G1 cells stabilizes Skp2 and Cks1, with a consequent increase in p21 and p27 proteolysis. Depletion of Cdh1 also increases the percentage of cells in S phase, whereas concomitant downregulation of Skp2 reverses this effect, showing that Skp2 is an essential target of APC/C(Cdh1). Expression of a stable Skp2 mutant that cannot bind APC/C(Cdh1) induces premature entry into S phase. Thus, the induction of Skp2 and Cks1 degradation in G1 represents a principal mechanism by which APC/C(Cdh1) prevents the unscheduled degradation of SCF(Skp2-Cks1) substrates and maintains the G1 state.
Skp2及其辅因子Cks1是SCF(Skp2 - Cks1)(Skp1/Cul1/F - 盒蛋白)泛素连接酶复合物的底物靶向亚基,该复合物通过诱导细胞周期蛋白依赖性激酶抑制剂p21和p27的降解来调节进入S期(参考文献1)。Skp2是一种癌蛋白,在人类癌症中通常表达增加;然而,调节其细胞丰度的机制尚不清楚。在这里,我们表明Skp2和Cks1蛋白在G1期不稳定,并且它们的降解由泛素连接酶APC/C(Cdh1)(后期促进复合物/细胞周期体及其激活剂Cdh1)介导。在G1期细胞中通过RNA干扰使Cdh1沉默可使Skp2和Cks1稳定,从而导致p21和p27蛋白水解增加。Cdh1的缺失也增加了S期细胞的百分比,而同时下调Skp2可逆转这种效应,表明Skp2是APC/C(Cdh1)的重要靶点。一种不能结合APC/C(Cdh1)的稳定Skp2突变体的表达会诱导细胞过早进入S期。因此,在G1期诱导Skp2和Cksl降解是APC/C(Cdh1)防止SCF(Skp2 - Cks1)底物意外降解并维持G1期状态的主要机制。